ANAshwin N. AnanthakrishnanJul 7, 2026New paperautoPaperCancer risk with methotrexate-TNF antagonist combination therapy compared to TNF-antagonist monotherapy in IBDInflammatory Bowel Diseases · 2026 · Sama Anvari, Wasuwit Wanchaitanawong, Xin Xiong et al.